مطالعه پایداری سویه AIK-C سرخک، سویه RS-12 اوریون و سویه Takahashi سرخجه در واکسن MMR

Allison, L.M., Mann, G.F., Perkins, F.T., Zuckerman, A.J., 1981. An accelerated stability test procedure for

lyophilized measles vaccines. J Biol Stand 9, 185-194.

Bishai, D.M., Bhatt, S., Miller, L.T., Hayden, G.F., 1992. Vaccine storage practices in pediatric offices. Pediatrics

89, 193-196.

Colinet, G., Rossignol, J., Peetermans, J., 1982. A study of the stability of a bivalent measles--mumps vaccine. J Biol

Stand 10, 341-346.

Der Yuan, W., Ruoh Ing, Y., Yi Chen, Y., Sheng Yen, Y., Tso Ling, C., Hwei Fang, C., Juen Tian, H., Chia Po, L.,

2000. The relationship between the cold chain system and vaccine potency in taiwan: (II) Oral polio vaccine. J Food

Drug Anal 8, 17-23.

Egan, W., Schofield, T., 2009. Basic principles of stability. Biological 37, 379- 386.

Freshney, R.I., 2005. Culture of Animal cells, A john wiley & song, Inc, Hoboken, New jersey.

Galazka, A., Milstien, J., Zaffran, M., 1998. Thermo stability of vaccines. WHO/GPV 98.07.

Knezevic, I., 2009. Stability evaluation of vaccines: WHO approach. Biologicals 37, 357-359; discussion 421-353.

Krause, P.R., 2009. Goals of stability evaluation throughout the vaccine life cycle. Biologicals 37, 369-378;

discussion 421-363.

Mann, G.F., Allison, L.M., Lloyd, J.S., Tam, P., Zuckerman, A.J., Perkins, F.T., 1983. Stability of furtherattenuated

measles vaccines. Rev Infect Dis 5, 482-486.

McAleer, W.J., Markus, H.Z., McLean, A.A., Buynak, E.B., Hilleman, M.R., 1980. Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. J Bio Stand 8, 281-287.

Pfleiderer, M., 2009. Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life an always reliable approach. Biologicals 37, 364-368.

Pharmacopoeia, B., 2012. The Stationery Office on behalf of the Medicines and Healthcare products Regulatory

Agency (MHRA), London.

Philip, R.K., 2009. Goal of stability evaluation throughout the vaccine life cycle. Biological 37, 369- 378.

Plotkin, S.A., Orenstein, W.A., Offit, P.A., 2008. Vaccine, WB Saunders Company, Philadelphia.

Schofield, T.L., 2009a. Maintenance of vaccine stability through annual stability and comparability studies. Biologicals 37, 397-402.

Schofield, T.L., 2009b. Vaccine stability study design and analysis to support product licensure. Biological 37 387-

396.

Shayestehpour, M., Shahkarami, M.K., Shafyi, A., Taqavian, M., Kamali Jamil, R., EsnaAshari, F., Mohammadi, A., Shahbazi, R., 2012. A study of the thermal stability of measles vaccine produced by AIK-C strain. Arak Med University J 15, 26-32.

Socarras, S., Magari, R.T., 2009. Modeling the effects of storage temperature excursions on shelf life. J Pharm

Biomed Anal 49, 221-226.

WHO, 1994. Recommendation for the production and control of measles, mumps, rubella and MMR vaccine.

WHO technical report series. expert committee on biological standardization.

WHO, 1995. Manual of laboratory methods for testing the potency of final vaccines used in the WHO expanded

program on immunization. 95.91, 91-106.